VOYA Investment Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Buy
48,843
+6,854
+16% +$33.5K ﹤0.01% 2083
2026
Q1
$180K Sell
41,989
-57,791
-58% -$322K ﹤0.01% 2128
2025
Q4
$894K Buy
99,780
+53,177
+114% +$329K ﹤0.01% 1514
2025
Q3
$172K Sell
46,603
-22,599
-33% -$61.6K ﹤0.01% 2216
2025
Q2
$135K Buy
69,202
+17,801
+35% +$37.1K ﹤0.01% 2416
2025
Q1
$90.5K Sell
51,401
-5,123
-9% -$11.7K ﹤0.01% 2454
2024
Q4
$150K Sell
56,524
-3,813
-6% -$9.82K ﹤0.01% 2477
2024
Q3
$138K Sell
60,337
-496
-0.8% -$1.51K ﹤0.01% 2585
2024
Q2
$178K Buy
60,833
+8,828
+17% +$26.9K ﹤0.01% 2506
2024
Q1
$189K Sell
52,005
-12,299
-19% -$23.6K ﹤0.01% 2476
2023
Q4
$97.1K Hold
64,304
– – ﹤0.01% 2762
2023
Q3
$86.2K Hold
64,304
– – ﹤0.01% 2766
2023
Q2
$116K Buy
64,304
+18,135
+39% +$30.8K ﹤0.01% 2746
2023
Q1
$76.6K Hold
46,169
– – ﹤0.01% 2743
2022
Q4
$88.6K Hold
46,169
– – ﹤0.01% 2776
2022
Q3
$103K Hold
46,169
– – ﹤0.01% 2772
2022
Q2
$150K Sell
46,169
-14,101
-23% -$61.5K ﹤0.01% 2507
2022
Q1
$317K Buy
60,270
+3,089
+5% +$17.4K ﹤0.01% 2150
2021
Q4
$486K Buy
57,181
+31,533
+123% +$290K ﹤0.01% 2035
2021
Q3
$255K Buy
25,648
+11,559
+82% +$105K ﹤0.01% 2435
2021
Q2
$131K Buy
+14,089
New +$161K ﹤0.01% 2714

Other funds holding NUVB

VOYA Investment Management's NUVB Position: Q2 2026 in Review

VOYA Investment Management increased its Nuvation Bio (NUVB) stake by 16% in Q2 2026, buying an estimated $33.5K and bringing the position to 48,843 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

VOYA Investment Management first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $894K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • VOYA Investment Management held 48,843 shares of Nuvation Bio worth $277K as of Q2 2026.
  • VOYA Investment Management bought 6,854 Nuvation Bio shares in Q2 2026, an estimated $33.5K.
  • Nuvation Bio made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2083 holding.
  • VOYA Investment Management first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
  • VOYA Investment Management's Nuvation Bio position peaked at $894K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.